文献速递外周动脉疾病

成本上升与住院时间延长背景下外周动脉疾病的治疗

Treating Peripheral Artery Disease in the Wake of Rising Costs and Protracted Length of Stay.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

本研究基于血管质量倡议(VQI)数据,分析2010至2015年接受下肢旁路术的患者,确定延长住院(LOS>7天)的相关因素及额外费用。多变量回归识别紧急手术、严重肢体缺血、重返手术室、使用静脉及出院抗凝为独立预测因素。延长住院增加总费用40561.64美元,但随访中保肢率和总生存率未受影响。

要点

  • 紧急手术、严重肢体缺血、重返手术室、使用静脉和出院抗凝是LOS>7天的独立预测因素。
  • 延长住院增加总费用40561.64美元和直接费用26028美元,但保肢和生存未受影响。
  • 下肢旁路术患者资源消耗大,但保留保肢和生存下成本值得。

核心结论

  • 下肢旁路术后延长住院与紧急手术、严重肢体缺血、重返手术室、使用静脉及出院抗凝独立相关。
  • 延长住院显著增加总费用和直接费用,但随访中保肢率和总生存率未受不利影响。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议(VQI)2010至2015年接受下肢旁路术的334例患者数据。
  • 进行汇总统计、t检验和χ2检验,并采用多变量逻辑回归确定延长住院的独立预测因素。

主要发现

  • 患者平均年龄66.4±12.4岁,男性64.7%,白人58.5%,透析11.1%,吸烟80.5%,糖尿病53.6%。
  • 平均住院时间15.7±12.2天。
  • 延长住院组与转院(15.4% vs. 2.3%,P=0.001)、糖尿病(58.3% vs. 40.2%,P=0.004)、严重肢体缺血(71.3% vs. 49.4%,P<0.001)等相关。
  • 多变量回归显示紧急手术(OR=5.09,95%CI 2.16-12.02,P<0.001)、严重肢体缺血(OR=3.12,95%CI 1.65-5.90,P<0.001)、重返手术室(OR=40.30,95%CI 5.36-303.20,P<0.001)、使用静脉(OR=2.19,95%CI 1.18-4.07,P=0.013)、出院抗凝(OR=2.56,95%CI 1.03-6.33,P=0.043)为独立预测因素。
  • 延长住院增加总费用40561.64美元和直接费用26028美元。

临床怎么用

  • 识别高危患者(如紧急手术、严重肢体缺血、需重返手术室)以优化资源分配和住院管理。
  • 尽管费用增加,但保肢和生存获益支持对下肢旁路术患者的资源投入。

局限性

  • 研究基于单一医疗系统数据,可能限制普遍性。
  • 回顾性设计可能引入选择偏倚。
  • 未详细说明费用计算方法和随访时长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been growing scrutiny in the treatment of patients with peripheral artery disease due to the utilization of resources to manage this complex patient population. The purpose of this study was to determine the factors associated with prolonged length of stay (LOS > 7 days) following lower extremity bypass using data from the Vascular Quality Initiative as well as to define the additional costs incurred due to prolonged LOS in our health system. METHODS: Summary statistics were performed of patients undergoing lower extremity bypass from 2010 to 2015. Student's t-tests and χ2 tests were performed to compare those with and without prolonged LOS. Multivariable logistic regression was then performed to determine the independent predictors for increased LOS. We then compared our institutional LOS with that of representative institutions from the University Health System Consortium and evaluated the impact of prolonged LOS on limb salvage and survival. RESULTS: This study included 334 patients with a mean age of 66.4 ± 12.4 years, 64.7% males, 58.5% of white race, 11.1% on dialysis, 80.5% smokers, and 53.6% with diabetes. The mean LOS was 15.7 ± 12.2 days. Prolonged LOS was associated with transfer (15.4% vs. 2.3%, P = 0.001), diabetes (58.3% vs. 40.2%, P = 0.004), critical limb ischemia (71.3% vs. 49.4%, P < 0.001), preoperative need for ambulatory assistance (44.5% vs. 16.1%, P < 0.001), prior ipsilateral bypass (6.9% vs. 1.1%, P = 0.042), urgent surgery (39.7% vs. 9.8%, P < 0.001), tibial or distal target vessel (52.7% vs. 28.0%, P < 0.001), use of vein (65.4% vs. 46.3%, P = 0.002), return to operating room (42.6% vs. 1.2%, P < 0.001), ambulatory assistance (65.0% vs. 34.1%, P < 0.001) as well as discharge anticoagulant (22.8% vs. 9.8%, P = 0.010). Multivariable logistic regression identified urgency (odds ratio [OR] = 5.09, 95% confidence interval [CI] 2.16-12.02, P < 0.001), critical limb ischemia (OR = 3.12, 95% CI 1.65-5.90, P < 0.001), return to OR (OR = 40.30, 95% CI 5.36-303.20, P < 0.001), use of vein (OR = 2.19, 95% CI 1.18-4.07, P = 0.013), and the need for anticoagulation at discharge (OR = 2.56, 95% CI 1.03-6.33, P = 0.043) as independent predictors of LOS > 7 days. Prolonged hospital stays accounted for an additional $40,561.64 in total cost and $26,028 in direct costs incurred. Despite these increased costs, limb salvage and overall survival were not adversely impacted in the prolonged LOS group in follow-up. CONCLUSIONS: Lower extremity bypass is associated with a longer than expected LOS in our health system, much of which can be attributed to return to the OR for minor amputations and wound issues. This led to added total and direct costs, where the majority of this increase was attributable to prolonged LOS. Limb salvage and overall survival were preserved, however, in this subset of patients in follow-up. These findings suggest that lower extremity bypass patients are a resource-intensive population of patients, but that these costs are worthwhile in the setting of preserved limb salvage and overall survival.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang GJ, Jackson BM, Foley PJ, et al. Treating Peripheral Artery Disease in the Wake of Rising Costs and Protracted Length of Stay. Ann Vasc Surg. 2017. PMID: 28479423. doi:10.1016/j.avsg.2017.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。